Original Query: ALL
Previous Study | Return to List | Next Study

Radiofrequency of Breast Cancers in Non Surgical Patients (RF SEIN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00210223
Recruitment Status : Completed
First Posted : September 21, 2005
Last Update Posted : July 26, 2013
Information provided by:
Institut Bergonié

Brief Summary:
To treat breast tumors in non surgical patients with percutaneous technique (radiofrequency). Prospective evaluation of treatment efficiency and tolerance based on clinical and radiological evaluation

Condition or disease Intervention/treatment
Breast Cancer Procedure: Radiofrequency

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 15 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Radiofrequency of Breast Cancers : Pilot Study in Non Surgical Patients
Study Start Date : April 2004
Study Completion Date : July 2006

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Breast Cancer
U.S. FDA Resources

Primary Outcome Measures :
  1. To know at 6 months the efficacy of radiofrequency based on
  2. - no local recurrence (detected with magnetic resonance imaging)
  3. - no palpable mass on clinical examination

Secondary Outcome Measures :
  1. To evaluate every 2 months, until 6 months :
  2. - the late complications of the percutaneous technique
  3. - the pain felt by the patients, during and after the radiofrequency

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   70 Years and older   (Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion criteria:

  • Patients more than 70 years old
  • Breast tumors with estrogen receptors
  • Non surgical patients
  • Life expectancy more than 6 months

Exclusion criteria:

  • Presence of a pace maker
  • Tumors measuring more than 30 mm on ultrasound evaluation, located less than 10 mm from skin, nipple, or pectoral muscle
  • Coagulation disorders
  • Contra indications to magnetic resonance imaging or computed tomography with contrast medium injection
  • Non visible lesions on magnetic resonance imaging or computed tomography with contrast medium injection

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00210223

Institut Bergonié - Centre Régional de Luttre Contre le Cancer de Bordeaux et du Sud Ouest
Bordeaux, France, 33076
Sponsors and Collaborators
Institut Bergonié
Principal Investigator: Fabienne VALENTIN, MD Institut Bergonié Identifier: NCT00210223     History of Changes
Other Study ID Numbers: IB2004-16
First Posted: September 21, 2005    Key Record Dates
Last Update Posted: July 26, 2013
Last Verified: October 2007

Keywords provided by Institut Bergonié:
Percutaneous technique
breast cancer

Additional relevant MeSH terms:
Breast Neoplasms
Neoplasms by Site
Breast Diseases
Skin Diseases